1 of 1
Story summary
- Dr. Tracy Beth Hoeg, the FDA's top drug regulator, is prioritizing a petition from Dr. Adam Urato to add warnings about pregnancy risks from selective serotonin reuptake inhibitors (SSRIs).
- Urato claims these medications may cause miscarriages and developmental disorders in children.
- Critics say the petition rests on weak data and could deter pregnant women from needed treatment, with experts calling for more research to understand the full impact.
